SlidesetHIVRSVCOVID-19OncologyInternational Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021 - Historical Perspectives from Pasteur to Flexner: The Evolution of Serum to Monoclonal Antibody Therapy- Charles W. FlexnerView Slideset
SlidesetHIVRSVCOVID-19OncologyMonoclonal Antibodies Against COVID-19: Targets, Development and Clinical Applications - Brigette Autran, MD, PhDView Slideset
SlidesetHIVRSVCOVID-19OncologyMonoclonal Antibodies for Treatment in COVID-19 - Florence Ader, Prof, MDView Slideset
SlidesetHIVRSVCOVID-19OncologyMonoclonal Antibodies for Prevention of HIV, COVID, and Ebola - Myron Cohen, MD, BSView Slideset
SlidesetHIVRSVCOVID-19OncologyMonoclonal Antibodies for Treatment in Autoimmune Diseases - Karmela Kim Chan, MDView Slideset
SlidesetHIVRSVCOVID-19OncologyMonoclonal Antibodies for Treatment in Hematologic Malignancies - Alison Moskowitz, MDView Slideset
SlidesetHIVRSVCOVID-19OncologyHow to Determine the Dosing (in Different Populations/Tissues) - Edmund Capparelli, PharmDView Slideset
SlidesetHIVRSVCOVID-19OncologyHow Will Technology Evolve: Modification of Antibodies - Boris Juelg, MD, PhDView Slideset
SlidesetHIVRSVCOVID-19OncologyInternational Workshop on Monoclonal Antibodies fo-r HIV, COVID-19, and Oncology 2021 - Implementing Monoclonal Antibodies for Treatment and Prevention in Resource-Limited Settings - How to Make Them Affordable - David RipinView Slideset
SlidesetHIVRSVCOVID-19OncologyHow Will Technology Evolve Delivery Methods and Formulations - Eric Andrew Appel, PhDView Slideset
